Trial intelligence / Profile preview

Oxaliplatin and vinorelbine in metastatic breast cancer (phase II)

2004-005250-31Phase 2Completed

Sponsor
Azienda per i Servizi Sanitari 1 Triestina
Start
Feb 2007
Modality
Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of oxaliplatin and vinorelbine in breast cancer, sponsored by Azienda per i Servizi Sanitari 1 Triestina. Started Feb 2007; status: completed.

02

Drugs

oxaliplatinvinorelbine
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2004-005250-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-005250-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call